What is the newest biologic for psoriasis? Exploring the latest advancements
•
3 min read
According to the National Psoriasis Foundation, the newest biologic for psoriasis, bimekizumab (Bimzelx), was approved by the FDA in October 2023 for adults with moderate to severe plaque psoriasis. This monoclonal antibody offers a new mechanism of action by blocking two key inflammatory proteins simultaneously.
